FEATURES OF THE MANAGEMENT OF PATIENTS WITH EXACERBATION OF ATOPIC DERMATITIS AGAINST THE BACKGROUND OF PREGNANCY


DOI: https://dx.doi.org/10.18565/pharmateca.2018.s1.47-51

K.N. Monakhov, N.A. Kholodilova

Department of Dermatovenerology with the Clinic of the Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia
Objective: to evaluate the effecacy, safety and tolerability of a series of Neotanine preparations in pregnant women with exacerbation of atopic dermatitis (AD). Methods. 21 pregnant women with exacerbation of AD at the age of 20 to 40 years were examined at the gestation age of 8 to 30 weeks. The diagnosis was confirmed based on data of medical history and clinical picture of the disease.
The examination was carried out 5 times for 14–16 days, therapy was prescribed by 2 stages. At the first stage (1–5 days), Neotanine spray or lotion (suspension) was prescribed 3–4 times a day until the elements were completely dried. At this stage, the patients were divided into 2 groups. Patients of the first group (11 persons) were prescribed Neotanine lotion; the use of Neotanine spray was recommended for patients of the second group (10 persons). At the second stage, all patients were prescribed Neotanine cream until the disappearance of the skin manifestations. Results. After the therapy, almost all patients managed to achieve positive results. Conclusion. The results of this study allow to recommend the Neotanin preparations as a safe and effective means that can be used in the treatment of pregnant women suffering from AD.
Keywords: atopic dermatitis, pregnancy, Neotanine preparations, antihistamines, itching

About the Autors


Corresponding author: O.N. Kholodilova – PhD, Teaching Assistant at the Department of Dermatovenereology with the Clinic of the Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia; e-mail: cholnatalex23@rambler.ru


Бионика Медиа